Literature DB >> 17233813

The immortalized cell lines with differentiation potentials: their establishment and possible application.

Masuo Obinata1.   

Abstract

Approximately 200 types of the cells are qualified as differentiated cells in the human body. If these different types of cells can be separated from each other (or cloned) and obtained in sufficient quantity, it will be beneficial for studying development, morphogenesis, tissue maintenance, cancer and aging, and for reconstructing functional tissues in vitro for regenerative medicine. We produced the transgenic mouse and rat harboring SV40 T-antigen gene to make the immortalized cell lines in the primary tissue culture and succeeded in establishing many functionally active cell lines from various tissues. Many immortalized cell lines from various tissues are shown to exhibit the unique characteristics of tissue functions and they should be useful as an in vitro model of various tissues for physiological and pharmacological investigations. Future application of these cells to drug screening is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17233813     DOI: 10.1111/j.1349-7006.2007.00399.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  11 in total

Review 1.  Cellular models for disease exploring and drug screening.

Authors:  Zhi-Kun Li; Qi Zhou
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

2.  Efficient isolation of bone marrow adipocyte progenitors by silica microbeads incubation.

Authors:  Qiqi Lu; Hua Liu; Tong Cao
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

Review 3.  Invitromatics, invitrome, and invitroomics: introduction of three new terms for in vitro biology and illustration of their use with the cell lines from rainbow trout.

Authors:  Niels C Bols; Phuc H Pham; Vivian R Dayeh; Lucy E J Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-04-03       Impact factor: 2.416

4.  Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema.

Authors:  Teruyo Kida; Hidehiro Oku; Taeko Horie; Masanori Fukumoto; Yoshitaka Okuda; Seita Morishita; Tsunehiko Ikeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-16       Impact factor: 3.117

5.  Primary Swine Respiratory Epithelial Cell Lines for the Efficient Isolation and Propagation of Influenza A Viruses.

Authors:  Victoria Meliopoulos; Sean Cherry; Nicholas Wohlgemuth; Rebekah Honce; Karen Barnard; Phillip Gauger; Todd Davis; Peter Shult; Colin Parrish; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

Review 6.  Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.

Authors:  Akikazu Sakudo; Takashi Onodera
Journal:  Front Cell Dev Biol       Date:  2015-01-15

7.  Development of oral epithelial cell line ROE2 with differentiation potential from transgenic rats harboring temperature-sensitive simian virus40 large T-antigen gene.

Authors:  Yoshiaki Tabuchi; Shigehito Wada; Mika Ikegame; Ayako Kariya; Yukihiro Furusawa; Nobuhiko Hoshi; Tatsuya Yunoki; Nobuo Suzuki; Ichiro Takasaki; Takashi Kondo; Yoshihisa Suzuki
Journal:  Exp Anim       Date:  2014

Review 8.  Thymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice Models.

Authors:  José E Belizário; Wesley Brandão; Cristiano Rossato; Jean Pierre Peron
Journal:  Mediators Inflamm       Date:  2016-05-30       Impact factor: 4.711

9.  Effects of an Aquaporin 4 Inhibitor, TGN-020, on Murine Diabetic Retina.

Authors:  Shou Oosuka; Teruyo Kida; Hidehiro Oku; Taeko Horie; Seita Morishita; Masanori Fukumoto; Takaki Sato; Tsunehiko Ikeda
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 10.  Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Pim R R van Gorp; Serge A Trines; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Front Cardiovasc Med       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.